Healthy for your Heart? Naturally?! Let s prove it!

Similar documents
About BACCHUS. fp7.eu fp7.eu

Science for a healthy society. Food Safety & Security. Food Databanks. Food & Health. Industrial Biotechnology. Gut Health

Polyphenols, cardiovascular disease and health claims Paul A Kroon

Science for a healthy society. Food Safety Centre. Food Databanks. Food & Health. Industrial Biotechnology. Gut Health

Smaller Waistlines, Sharper Minds, Stronger Bones and Healthier Hearts?

chapter 1 Chapter 2 chapter 3

Exploring the Resurgence of Cocoa Antioxidants

The Cell Therapy Catapult

European Technology Platform Food for Life

CRT Plenary Meeting Proposed topics for future workshops and workstreams

EU S NUTRITION AND HEALTH CLAIM LEGISLATION: CONSUMER AND INNOVATION ASPECTS

Nuts & Chocolate: The Perfect Pair

The benefits of prevention: healthy eating and active living

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

How To Understand The Paediatric Regulation

Chocolate and Cocoa in Medicine

Clinical research trials and insurance

CLINICAL TRIALS WITH MEDICINES IN EUROPE

How To Know If Coffee Increases Type 2 Diabetes Risk

Neal Rouzier responds to the JAMA article on Men and Testosterone

What are observational studies and how do they differ from clinical trials?

Reversing Childhood Obesity by 2015 The New Childhood Obesity Advocacy Initiative Voices for Healthy Kids

U.S. Food and Drug Administration

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:

Bayer Pharma AG Berlin Germany Tel News Release. Not intended for U.S. and UK Media

SPORTS STADIUM AND COMMUNITY HEALTH

Food supplements. Summary information on legislation relating to the sale of food supplements

Landscape. Nordic Oat Days Viola Adamsson

Your Results. For more information visit: Name: Date: In partnership with

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission

CITY OF EAST PALO ALTO A COMMUNITY HEALTH PROFILE

A Home-Based Care Model for Outpatient Cardiac Rehabilitation Based on Mobile Technologies

Research Design Service London

A Guide to Horizon 2020 Funding for the Creative Industries

Disruptive Dairy innovation: Why has it become a necessity for the food industry?

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care

Karen Kovach M.S, R.D Chief Scientific Officer Weight Watchers International Inc.

The Peanut Institute Update SALLY TABB WELLS

Comments from the Federal Institute for Risk Assessment (BfR), Germany on EFSA's draft scientific opinion on the safety of caffeine

Know your Numbers The D5 Goals for Diabetes Care. Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014

A study on new products. available in India for. diabetics. Note: Source:

State Wellness Program

For personal use only

Exercise, Health and Lifestyle

The Clinical Trials Process an educated patient s guide

Public health priorities in Sweden

Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland

Cost-Effectiveness Analysis (CEA)

Model of Intelligence

Rowlands Growth Capital Review

Pharmacology skills for drug discovery. Why is pharmacology important?

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

Risk Factors for Fire Fighter Cardiovascular Disease

Corporate Wellness as a Business Strategy

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

Food Health Claims Physical Performance

The Impact of Polyphenolic Compounds on Apoptosis in Epithelial Cells

Russell Group response to the Government Review of the Balance of Competences between the UK and EU: Research and Development

Rapid review of the evidence Effectiveness of food reformulation as a strategy to improve population health

Regulatory Issues in Genetic Testing and Targeted Drug Development

Corporate Wellness: Facts & Figures

1 An introduction to health psychology

Nutrition and health claims

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

and Horizon 2020 the future calls Brendan Hawdon Head of Unit Framework Programme European Commission DG Research & Innovation

David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing»

Counting all the costs: the economic costs of comorbidities

Life Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com

Action Plan: National Program 107 Human Nutrition

Alexandra Bargiota Assist. Prof. in Endocrinology University Hopsital of Larissa Thessaly, Greece.

Horizon 2020 EU s 8th framework programme for research and innovation

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

EU Joint Programming Initiative A Healthy Diet for a Healthy Life (JPI HDHL)

Healthcare System Design. Professional Degree of Engineering

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

To find out more, please contact your Capita consultant or visit

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

UK Patients with Chronic Conditions Believe the Ability to Access Electronic Medical Records Outweighs Concern of Privacy Invasion

Wellness CORPORATE 2

Why Are Drugs So Expensive? Learning About the Drug Development Process

Dietary Guidance Statements An Industry Perspective

HSA Consumer Guide. What is HSA s role in regulating the advertisements of health supplements?

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

the EU framework programme for research and innovation

ESKITP Assist in the preparation of change management plans and assignments for IT enabled systems 1

IP specificities in research for the benefit of SMEs

How To Plan Healthy People 2020

Jill Malcolm, Karen Moir

EBiSC: The European Bank for induced pluripotent Stem Cells

Dark chocolate as a functional food

Effects of macronutrients on insulin resistance and insulin requirements

North Lewisham Health Needs New Cross Ward Assembly 21st of May

Yoga for Eating Disorders: A Critical Look at Obesity Treatment and Prevention Nina Marie Collins, Subtle Yoga Teacher Training Student, lfall 2009

Title. Enterprise Europe Network & Innovate UK

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and

An Introduction to Valuations

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s)

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Setting Targets for Objectives

Bring the proof of Health Effect

Transcription:

Let s prove it!

Let s prove it!

Let s prove it!

Let s prove it!

Let s prove it!

pomegranate ancient Khorasan wheat apple aronia/chokeberry sweet orange bioactive peptide...what do these foods have in common? All of these foods (and their components) are thought to help keep our heart healthy. The goal of BACCHUS is to show scientifically that foods we eat influence cardiovascular health positively reducing risk or helping unhealthy hearts get better. How can this be of use to you? Read more...

About Bacchus BACCHUS is a four-year FP7-KBBE-funded Collaborative (Research) Project targeted at a special group (SMEs), with 28 Beneficiaries including 15 SMEs from 11 countries, led by the Institute of Food Research (IFR, UK). What do we do? Our objective is to develop tools and resources that will facilitate the generation of robust and exploitable scientific evidence, which can be used to support health claims for a cause-and-effect relationship between consumption of bioactive peptides and polyphenols, and beneficial physiological effects related in cardiovascular function. For more information visit: www.bacchus-fp7.eu

Why are we doing it? Over the last few years, we have seen a rise in cardiovascular disease (CVD). Currently, this is responsible for 47% of deaths in Europe, putting pressure on international health programmes to meet targets for reducing associated risk factors, such as high blood pressure and cholesterol. Ever increasing healthcare costs, which currently total ca. 195 billion ( 157 bn), and the impact of ill health on individuals, make measures to reverse this trend essential. Consumption of polyphenols can help reduce the risk of CVD, but pre-clinical research has also demonstrated that bioactive peptides and polyphenols can exert beneficial physiological effects on the unhealthy cardiovascular system (e.g. hypertension). This has driven further investment within the food industry, including SMEs. Despite submission of many dossiers seeking a favourable opinion from EFSA for health claims concerning polyphenols or peptides, few have been successful to date. There are specific challenges associated with proving scientifically any beneficial physiological relationship between markers for risk of CVD and consumption of bioactive peptides and polyphenols including: characterisation of the bioactive compounds, appropriate biomarkers, efficacy and dose in humans, and a plausible mechanism of action leading to a specific health claim.

What is our target? Existing food products, developed by SMEs, with clear potential for a favourable health claim have been selected and aligned with research addressing key aspects of health claim evaluation (e.g. legislation and dossiers, product bioactive characterisation, intake and bioavailability, mechanisms of action and biomarkers, randomised controlled trials). This approach will deliver tools, processes, scientific results and best practice guidelines, which will be made publically available to support future health claims. BACCHUS outcomes will be disseminated broadly within the SME food and retail community as well as traditional scientific routes. Who are we? www.ifr.ac.uk www.leeds.ac.uk www.tubitak.gov.tr www.csic.es www.nofima.no www.prodigest.eu www.ucc.ie www.srbnutrition.info www.unibo.it www.ugent.be www.vito.be www.nutrika.rs www.lgc.co.uk www.helsinki.fi/yliopisto www.nutrition.org.uk www.eurofir.net www.pamidainternational.com www.ucam.edu www.cremeglobal.com www.valdycomer.es www.industrias-vaquero.com www.wagralim.be www.criticalprocesses.com www.bioactor.com www.coressence.co.uk www.laboratoriosadmira.com www.bioaesis.com www.kamut.com For more information about BACCHUS visit www.bacchus-fp7.eu

Coordinator Paul Kroon Institute of Food Research Norwich Research Park Colney Lane, Norwich NR4 7UA, UK Telephone: +44 1603 251 431 Fax: +44 1603 251 470 E-mail: ifr.bacchus@ifr.ac.uk or contact@bacchus-fp7.eu RTD:3 SME:3 RTD:2 SME:4 RTD:2 SME:3

Let s prove it...